杭齒前進(601177.SH)終止發行不超3億元超短期融資券
格隆匯12月9日丨杭齒前進(601177.SH)公佈,公司擬在中國銀行間市場交易商協會申請註冊發行不超過人民幣3億元(含3億元)的超短期融資券。
自公司發行超短期融資券事項啟動以來,公司董事會、管理層與中介機構等一直積極推進相關工作,截至目前,本次超短期融資券尚未取得中國銀行間市場交易商協會批准註冊相關文件。鑑於公司目前負債結構,發行超短期融資券已不能實現公司優化融資結構的目的,經公司第五屆董事會第三次會議審議通過,公司決定終止本次超短期融資券發行事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.